Barclays’s Incannex Healthcare IXHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25K Hold
750
﹤0.01% 4839
2025
Q4
$8.06K Hold
750
﹤0.01% 4956
2025
Q3
$10.4K Hold
750
﹤0.01% 5019
2025
Q2
$4.85K Hold
750
﹤0.01% 4976
2025
Q1
$15.2K Hold
750
﹤0.01% 4820
2024
Q4
$47.7K Hold
750
﹤0.01% 4772
2024
Q3
$44.8K Hold
750
﹤0.01% 4772
2024
Q2
$66.2K Buy
+750
New +$64.7K ﹤0.01% 4098
2024
Q1
Hold
0
5029
2022
Q2
Sell
-14
Closed -$16K 5147
2022
Q1
$16K Buy
+14
New +$23.1K ﹤0.01% 4503

Other funds holding IXHL

Barclays's IXHL Position: Q1 2026 in Review

Barclays held its Incannex Healthcare (IXHL) position steady in Q1 2026 at 750 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #4839.

Barclays first reported a position in IXHL in Q1 2022 and has held it in 9 quarters since. The position peaked at $66.2K in Q2 2024. 21 funds tracked by Wall St. Rank hold IXHL as of Q1 2026.

  • Barclays held 750 shares of Incannex Healthcare worth $2.25K as of Q1 2026.
  • Barclays left its Incannex Healthcare share count unchanged in Q1 2026.
  • Incannex Healthcare made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4839 holding.
  • Barclays first reported a position in Incannex Healthcare in Q1 2022 and has held it in 9 quarters since.
  • Barclays's Incannex Healthcare position peaked at $66.2K in Q2 2024.
  • 21 funds tracked by Wall St. Rank held Incannex Healthcare as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.